GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNSF.L Regulatory News (NSF)

  • There is currently no data for NSF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: Non-Standard Finance (NSF): Reading the runes: strong, controlled growth

5 Dec 2018 14:23

Hardman & Co Research Hardman & Co Research: Non-Standard Finance (NSF): Reading the runes: strong, controlled growth 05-Dec-2018 / 14:22 GMT/BST


Hardman & Co Research: Reading the runes: strong, controlled growth

On 3 December, NSF held an investor day at the Reading branch of Everyday Loans (EL) and its head office in Bourne End. Investors and analysts thus got the opportunity to see the front-line operations and review the company's strategy. The former confirmed our view on the competitive advantages of a branch network and the operational synergies from being part of a group. The presentation confirmed the long-term, controlled growth opportunity from a business with an excellent market positioning and sustainable competitive advantages. We have not changed our forecasts following the update, and our absolute valuation range remains 91-101p. Please click here for the full report:

https://www.hardmanandco.com/research/corporate-research/reading-the-runes-strong-controlled-growth/

To contact us: Hardman & Co 35 New Broad Street London EC2M 1NH www.hardmanandco.comFollow us on Twitter @HardmanandCo Contacts: Mark Thomas +44 20 7194 7622 mt@hardmanandco.com

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 21 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

754839 05-Dec-2018 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
31st Oct 20174:40 pmRNSSecond Price Monitoring Extn
31st Oct 20174:35 pmRNSPrice Monitoring Extension
20th Oct 201712:06 pmRNSDirector/PDMR Shareholding
9th Oct 20179:57 amRNSHolding(s) in Company
28th Sep 20173:39 pmRNSGeorge Banco receives full FCA authorisation
19th Sep 20172:25 pmRNSHolding(s) in Company
23rd Aug 20177:00 amRNSNotification of Transactions of PDMRs
17th Aug 20173:42 pmRNSCompletion of acquisition of George Banco
11th Aug 20171:13 pmRNSHardman Research: H117 Delivering growth options
4th Aug 20177:00 amRNSDirector/PDMR Shareholding
3rd Aug 20177:01 amRNSAcquisition of George Banco, £225m term loan & RCF
3rd Aug 20177:00 amRNSUnaudited half year results to 30 June 2017
26th Jul 20173:01 pmRNSNotice of Results
25th Jul 20174:35 pmRNSPrice Monitoring Extension
5th Jun 20177:00 amRNSAppointment of joint broker
17th May 20177:00 amRNSLoans at Home receives full FCA authorisation
10th May 20172:52 pmRNSHolding(s) in Company
9th May 201712:50 pmRNSResult of AGM
9th May 20177:00 amRNSAGM Trading update
4th May 20172:02 pmRNSDirectorate Change
4th May 201711:03 amRNSHolding(s) in Company
3rd May 20171:51 pmRNSHolding(s) in Company
3rd May 20178:39 amRNSHolding(s) in Company
19th Apr 20174:52 pmRNSHolding(s) in Company
18th Apr 201712:41 pmRNSHolding(s) in Company
10th Apr 20172:55 pmRNSAnnual Financial Report
17th Mar 20177:00 amRNSExtension of Existing Bank Facilities
15th Mar 20173:46 pmRNSNotification under Listing Rule 9.6.14(2)
13th Mar 201710:42 amRNSHardman Research: Branching Out Invest Accelerated
3rd Mar 201712:45 pmRNSTimetable for final dividend
3rd Mar 20177:00 amRNSFinal Results
28th Feb 20178:00 amRNSMarket developments in home-collected credit
17th Jan 20177:00 amRNSPre-Close Trading Update
13th Jan 20174:40 pmRNSSecond Price Monitoring Extn
13th Jan 20174:35 pmRNSPrice Monitoring Extension
19th Dec 20169:30 amRNSDirectorate Change
1st Dec 20169:25 amRNSDirector/PDMR Shareholding
1st Dec 20169:25 amRNSDirector/PDMR Shareholding
29th Nov 20168:58 amRNSFCA review of high-cost credit and overdrafts
15th Nov 20164:25 pmRNSDirector/PDMR Shareholding
11th Nov 201610:05 amRNSHardman Research: "Carpe Diem"
10th Nov 20164:40 pmRNSSecond Price Monitoring Extn
10th Nov 20164:35 pmRNSPrice Monitoring Extension
1st Nov 20167:00 amRNSInvestor day and trading update
31st Oct 201611:10 amRNSDirectorate Change
27th Oct 201611:55 amRNSHolding(s) in Company
5th Sep 201611:48 amRNSTotal Voting Rights
4th Aug 201612:07 pmRNSSecond Price Monitoring Extn
4th Aug 201612:02 pmRNSPrice Monitoring Extension
3rd Aug 20167:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.